Source:http://linkedlifedata.com/resource/pubmed/id/16896030
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-8-9
|
pubmed:abstractText |
In colorectal tumorigenesis, Ki-ras proto-oncogene mutation often occurs early in the adenoma-adenocarcinoma sequence, whereas mutation of the p53 gene is associated with late progression to carcinoma. We evaluated the relationship of demographic and clinicopathologic characteristics to Ki-ras mutation and p53 gene product overexpression in 1,093 baseline sporadic colorectal adenomas from 926 individuals enrolled in a phase III recurrence prevention trial. Ki-ras mutation was found in 14.7% of individuals and p53 overexpression was found in 7.0% of those tested. Multivariate analysis found older age, rectal location, and villous histology to be independently associated with Ki-ras mutation. Individuals with an advanced adenoma (>or=1 cm or high-grade dysplasia or villous histology) had a 4-fold higher likelihood of Ki-ras mutation [odds ratios (OR), 3.96; 95% confidence intervals (CI), 2.54-6.18]. Ki-ras mutations in codon 12 and of the G-to-A transition type were more frequent in older individuals, whereas G-to-T transversion was more frequent in rectal adenomas than in the colon. Multivariate analysis showed that previous history of a polyp (P = 0.03) was inversely associated with p53 overexpression. Large adenoma size (>or=1 cm), high-grade dysplasia, and villous histology were independently associated with p53 overexpression, with the strongest association for advanced adenomas (OR, 7.20; 95% CI, 3.01-17.22). Individuals with a Ki-ras mutated adenoma were more likely to overexpress p53 (OR, 2.46; 95% CI, 1.36-4.46), and 94.8% of adenomas with both alterations were classified as advanced (P <or= 0.0001). Our large cross-sectional study supports the role of both Ki-ras and p53 in the progression of adenomas and shows that their molecular pathogenesis differs by anatomic location, age, and mucosal predisposition as evidenced by previous history of a polyp.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1055-9965
|
pubmed:author |
pubmed-author:AhnenDennis JDJ,
pubmed-author:AlbertsDavid SDS,
pubmed-author:BhattacharryaAchyut KAK,
pubmed-author:EinspahrJanine GJG,
pubmed-author:HamiltonStanley RSR,
pubmed-author:HoulihanP ScottPS,
pubmed-author:HsuChiu-HsiehCH,
pubmed-author:JacobsElizabeth TET,
pubmed-author:JiangRuiyunR,
pubmed-author:MartinezMaria ElenaME,
pubmed-author:RashidAsifA,
pubmed-author:WebbC ReneeCR
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1443-50
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:16896030-Adenocarcinoma,
pubmed-meshheading:16896030-Adenoma, Villous,
pubmed-meshheading:16896030-Adult,
pubmed-meshheading:16896030-Aged,
pubmed-meshheading:16896030-Aged, 80 and over,
pubmed-meshheading:16896030-Case-Control Studies,
pubmed-meshheading:16896030-Colorectal Neoplasms,
pubmed-meshheading:16896030-DNA Mutational Analysis,
pubmed-meshheading:16896030-Demography,
pubmed-meshheading:16896030-Female,
pubmed-meshheading:16896030-Genes, p53,
pubmed-meshheading:16896030-Genes, ras,
pubmed-meshheading:16896030-Humans,
pubmed-meshheading:16896030-Immunoenzyme Techniques,
pubmed-meshheading:16896030-Male,
pubmed-meshheading:16896030-Middle Aged,
pubmed-meshheading:16896030-Mutation,
pubmed-meshheading:16896030-Polymerase Chain Reaction
|
pubmed:year |
2006
|
pubmed:articleTitle |
Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.
|
pubmed:affiliation |
Department of Medicine, Arizona Cancer Center, P.O. Box 245024, Tucson, AZ 85724, USA. jeinspahr@azcc.arizona.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Clinical Trial, Phase III,
Research Support, N.I.H., Extramural
|